We assessed the total expression and subcellular localization of proteins involved in ER export processing of GPI-APs from the DLPFC of 15 matched pairs of SCZ and comparison subjects. Specifically, we measured levels of PGAP1 and Tmp21 (p24). Additionally, we performed a Triton X-114 phase separation to distinguish between membrane-associated and cytosolic forms of protein substrates. We confirmed the sensitivity of each target GPI-AP to phosphatidylinositol-specific phospholipase C (PI-PLC), an enzyme that specifically cleaves GPI from GPI-APs. Results: We found a significant decrease in p24 in total tissue homogenates and PGAP1 in an ER enriched fraction from subjects with SCZ. We also identified diminished sensitivity of the GPI-APs, GPC1 and NCAM, to PI-PLC treatment in SCZ. Discussion: Decreased PGAP1 in an ER enriched fraction in consistent with reduced inositol deacylation and potential dysfunction as the gatekeeper of GPI-AP ER exit in SCZ. This also suggests that the GPI-anchor is not correctly modified. Decreased p24 levels suggest downregulation of transport between the Golgi and the ER in SCZ. Additionally, we observed unchanged total level of GPI-APs in Triton X-114 phase separation, but a significant decrease in the amount of NCAM and GPC1 that was sensitive to PI-PLC in SCZ. This finding may be consistent with abnormal GPI modification of these two candidate proteins. Together, these findings suggest dysregulation of the GPI-APs remodeling system in SCZ, which may impact the structure of the GPI-anchor for SCZ-relevant proteins like NCAM and GPC1. 
F203. A META-ANALYSIS OF MINOR PHYSICAL ANOMALIES IN FIRST-DEGREE UNAFFECTED RELATIVES OF PATIENTS WITH SCHIZOPHRENIA
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Background: Neurodevelopmental abnormalities are common in schizophrenia. Minor physical anomalies (MPAs) are associated with abnormalities in neural development. Previous studies clearly demonstrated that MPAs are significantly increased in schizophrenia. However, the available evidence in unaffected relatives of patients with schizophrenia is contradictory. Methods: A literature search was conducted between 1 JAN 1980 and SEP 2017 in PUBMED and SCOPUS. Random-effects model was used. Heterogeneity was tested with Q test and I2. The meta-analysis was conducted using OpenMetaAnalyst software. Results: 16 studies were included in the meta-analysis. MPAs were significantly more common unaffected first-degree relatives of patients with schizophrenia (d=0.56, CI=0.40-0.73, p<0.001). There was a significant heterogeneity in distribution of effect sizes (Q=42.2, p<0.001). The level of this heterogeneity was medium in range (I2=64 %). In meta-regression analyses, demographic variables were not significantly related with magnitude of the effect size. Discussion: MPAs are associated with risk of schizophrenia. However, the level of heterogeneity suggests that risk of psychosis is associated with neurodevelopmental abnormalities in some but not all individuals. Findings also emphasize that resilience factors might be protecting many neurodevelopmentally impaired relatives of schizophrenia against having a full-blown psychotic disorder. Background: For decades familial high-risk studies have informed us about genetic and environmental risk factors for schizophrenia and recently also bipolar disorder. Familial high-risk studies are important and relevant and may represent a possible shortcut to learning more about early markers of illness, mental vulnerability and resilience. Methods: The Danish High Risk and Resilience Study -VIA 7 is a prospective cohort study of 522 7-year old children, 202 of them born to at least one parent diagnosed with schizophrenia in the Danish registries, 120 of them born to a least one parent diagnosed with bipolar disorder and 200 of them born to parents without any of these diagnoses. A comprehensive battery has been used combining assessments from several domains for both parents and children. Results: Results show that children born to parents with schizophrenia or bipolar disorder have higher frequencies of early mental problems. Further there are marked differences between the three groups concerning neuro cognition, motor functioning and living conditions including socioeconomic status, early risk factors and home environment -all factors that are known to be important with regard to healthy child development. Discussion: First results from the VIA 7-study indicate that many children and families have unmet needs and problems. Perspectives are two-fold: we aim to follow the cohort and conduct a new assessment before puberty (at age 11). Simultaneously, we are evolving an early, integrated, specialized and family based intervention, called VIA Family, to prevent or ameliorate development of severe mental illness in individuals born to parents with schizophrenia or bipolar disorder. Background: Olfactory dysfunction has repeatedly been observed in individuals diagnosed with schizophrenia. The most stable and consistent finding on the behavioral level is that of smell identification deficits. However, the nature of olfactory identification abnormalities seems to extend to structural abnormalities in the underlying neurobiology of the olfactory system. Furthermore, smell identification deficits are also documented in first-episode patients and non-psychotic first-degree relatives of schizophrenia patients. Family members of schizophrenia patients also show structural abnormalities of the olfactory system, suggesting that these may serve as an endophenotype for the development of schizophrenia.
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